Ozempic jab maker sheds pounds after drug results miss
It was one of the Danish pharma giant's worst days on the stock market, as its shares fell by up to 29 per cent. The company ...
Yahoo1d
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
Novo Nordisk CEO Lars Fruergaard Joergensen in December during a presentation of a new production site. The company's latest ...
Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results
Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...
The Progress-Index1d
Manufacturer of Ozempic says it will purchase AMPAC Fine Chemicals in Petersburg
Signs at AMPAC Fine Chemicals' location in the Petersburg Industrial Park have already been changed to 'Novo Nordisk' in advance of the acquisition ...
MIT Technology Review1d
Drugs like Ozempic now make up 5% of prescriptions in the US
“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
How to eat a healthy diet if you’re losing weight with Ozempic or Wegovy
Patients taking the drugs eat less and they can experience side effects such as nausea, so they should prioritize certain ...
Ozempic maker’s shares plunge after failed weight-loss trial
Shares in Novo Nordisk have fallen by more than a quarter after the Ozempic maker revealed a set of underwhelming results in ...
‘Biohacker’ Bryan Johnson microdosing on weight loss jabs to stay young as drugs ‘lower risk of cancer and Alzheimer’s’
MILLIONAIRE ‘biohacker’ Bryan Johnson has embarked on several wacky schemes in a bid to turn back the clock. They range from infusing his son’s plasma into his blood to injecting a ...
Zacks.com on MSN1d
LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List
The FDA removed Eli Lilly’s LLY tirzepatide injection products from the drug shortage list after determining that Lilly’s ...
Novo Nordisk’s next-generation weight-loss drug matches Lilly’s Zepbound in major trial, but doesn’t surpass it
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
Ozempic lures people to the doctor, Nestle's GLP-1 'shot,' an FDA Zepbound ruling: Pharma news roundup
Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...